Mark J. Ratain to HIV Protease Inhibitors
This is a "connection" page, showing publications Mark J. Ratain has written about HIV Protease Inhibitors.
Connection Strength
0.970
-
Drug Interactions With a Short Course of Nirmatrelvir and Ritonavir: Prescribers and Patients Beware. J Clin Pharmacol. 2022 08; 62(8):925-927.
Score: 0.837
-
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir Prescribing. Clin Pharmacol Ther. 2016 Apr; 99(4):363-9.
Score: 0.133